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Nonsynonymous/synonymous rate ration disease genes were investigated through a comparative analysis with mouse
mutant phenotype data. Mouse orthologs with mutations that resulted in discernible phenotypes were
separated from mutations with no phenotypic defect, listing ‘phenotype’ and ‘no phenotype’ genes. First, we
showed that phenotype genes are more likely to be disease genes compared to no phenotype genes. Pheno-
type genes were further divided into ‘embryonic lethal’, ‘postnatal lethal’, and ‘non-lethal phenotype’ groups.
Interestingly, embryonic lethal genes, the most essential genes in mouse, were less likely to be disease genes
than postnatal lethal genes. These ﬁndings indicate that some extremely essential genes are less likely to be
disease genes, although human disease genes tend to display characteristics of essential genes. We also
showed that, in lethal groups, non-disease genes tend to evolve slower than disease genes indicating a strong
purifying selection on non-disease genes in this group. In addition, phenotype and no phenotype groups
showed differing types of disease mutations. Disease genes in the no phenotype group displayed a higher
frequency of regulatory mutations while those in the phenotype group had more frequent coding mutations,
indicating that the types of disease mutations vary depending on gene essentiality. Furthermore, missense
disease mutations in no phenotype genes were found to be more radical amino acid substitutions than those
in phenotype genes.
© 2008 Elsevier Inc. All rights reserved.Introduction
‘Essential’ and ‘nonessential’ are classic molecular genetic ter-
minologies referring to the functional importance of a gene,
speciﬁcally with regard to its ﬁtness effect on an organism [1]. A
gene that is absolutely required for survival, or a gene that strongly
contributes to ﬁtness and robust competitive growth is considered to
be an essential gene [2]. On the contrary, a nonessential gene is
dispensable for viability, and its inactivation yields viable and fertile
individuals. Recently, several interesting ﬁndings have been made
regarding the discernible characteristics of essential genes in model
organisms. First, considering that strong purifying selection applied to
essential genes would result in a lower evolutionary rate, essential
genes have been shown to evolve more slowly than nonessential
genes [1,3,4], although some conﬂicts have been reported [5,6].
Second, essential genes are likely to encode hub proteins in protein–
protein interaction networks [7–10], suggesting that essential proteins
have more interacting partners within networks than nonessentialand Medical Biotechnology,
ational University, Chunchon
l rights reserved.counterparts. Third, essential genes are more likely to be abundantly
and ubiquitously expressed in cells and tissues [11,12] and have
smaller-sized introns [13–15].
Human disease genes are considered to represent a subset of
essential genes, given that heritable diseases generate discernible
phenotypic symptoms caused by deleterious effects of disease
mutations. To study this issue, various evolutionary features have
been compared between heritable disease genes and non-disease
genes [8,14,16,17]. Although most ﬁndings are generally consistent,
conﬂicting results have been occasionally reported. Lopez-Bigas and
Ouzounis [14] showed that human disease genes are more evolutio-
narily conserved than other genes, in agreement with the idea that
genes with strong ﬁtness effects should evolve more slowly than other
genes. In contrast, Huang et al. [16] found that nonsynonymous/
synonymous substitution rate ratios (Ka/Ks) in disease genes were
similar to those in non-disease genes. Smith and Eyre-Walker [22]
reported even higher Ka/Ks ratios in human disease genes than those
in non-disease genes. In the latter study, human disease genes were
shown to be expressed in a narrower range of tissues, contrary to the
observed features of essential genes. Recently, it was reported that
disease genes have a higher connectivity in networks than non-
disease genes, which is a signature of essential genes. However, many
human disease genes generate proteins located at the periphery of
415D. Park et al. / Genomics 92 (2008) 414–418networks [8], indicating human disease genes are a mixture of both
essential and nonessential genes. Some human genes essential in early
development contribute to the high rate of ﬁrst-trimester sponta-
neous abortions, which may account for as much as 20% of recognized
pregnancies. Since those essential genes are very likely to be non-
disease genes, human non-disease genes may also contain both
essential and nonessential genes. Hence, Tu et al. [17] subtracted a set
of deﬁned essential genes (i.e., ubiquitously expressed housekeeping
genes) from non-disease genes, concluding that disease genes have an
intermediate essentiality between housekeeping genes and other
human genes.
As it is impractical to experimentally estimate essentiality of
human genes in the manners performed for model organisms, we
utilized existing knowledge on essentiality of mouse orthologs as a
strategy to estimate essentiality of human genes. Mouse mutant
phenotype data are relatively extensive, and the evolutionary distance
between human and mouse is relatively short. It has been widely
accepted that homologous genes have similar functions if the twoFig. 1. The frequencies of human disease genes in different mouse phenotype groups were
divided into non-lethal and lethal genes (B), which were further divided into postnatal and em
(D). On X-axis, ‘a’, ‘b’, and ‘c’ indicate different ways to divide phenotype genes corresponding
postnatal and embryonic lethal genes (c). Conﬁdence intervals are displayed with capped baspecies are evolutionarily close, and that genes having essential
functions in mice frequently have accordingly pivotal functions in
humans. In the present study, we examined the likelihood of a gene
being linked to human disease, in relation to the level of essentiality of
the gene in mouse. In addition, by performing the analysis on the
subgroups of disease genes with different levels of essentiality, we
show that features of disease mutations on nonessential genes differ
from those on essential genes.
Results
Gene classiﬁcations
Candidate genes were classiﬁed in two different ways; (i)
phenotypic defects produced by a mutation on the mouse ortholog,
or (ii) linkage of the human ortholog with a disease. A total of 4004
mouse orthologswithmutant phenotype datawere collected fromMGI
(http://www.informatics.jax.org, see Materials and methods). Wecalculated and compared with those in no phenotype genes. Phenotype genes (A) were
bryonic lethal genes (C). Statistical signiﬁcance was tested by logistic regression model
to panels A, B, and C, respectively; phenotype (a), non-lethal and lethal (b), or non-lethal,
rs.
Fig. 3. The frequencies of various mutation types in disease genes were calculated and
compared between phenotype and no phenotype genes.
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mutation on the mouse ortholog resulted in abnormal phenotype(s),
including lethality. Hereafter, this group of genes will be abbreviated as
‘P’ genes. The genes at which null mutations in mouse do not result in
any overt phenotypic abnormality were categorized as having no
phenotype (NP). P geneswere further divided into lethal phenotype (P-L)
and non-lethal phenotype (P-NL) groups. In some subsequent analyses,
P-L genes were further divided into embryonic lethal (P-L-Em) and
postnatal lethal (P-L-Po) subgroups. Then, we determined whether
those genes are linked with human diseases, using the list of 2789
disease genes obtained from HGMD (http://www.hgmd.cf.ac.uk/ac/
index.php, see Materials and methods). All the genes and their
information analyzed in this studywere summarized in Supplementary
Table 1A, 1B, 2A, and 2B (see Materials and methods).
Phenotype genes in mouse are more likely to be disease genes in human
Weﬁrst investigatedwhether P genes (i.e. geneswithﬁtness effects)
in mouse are really more likely to be disease genes in human than NP
genes (i.e. genes with no ﬁtness effects). As shown in Fig. 1A, about 36%
(1311/3635) of P genes versus only 17% (63/369) ofNP geneswere found
to be human disease genes, indicating that P genes are signiﬁcantly
more likely to be disease genes (p=3.15×10−6, odds ratio=1.16, Fig.1D).
Statistical signiﬁcance was estimated by logistic regression analysis (as
described in Materials and methods). Next, we tested whether or not
the severity of mouse phenotypes is associated with the frequency of
disease genes. It was expected that the likelihood of a protein being
involved in diseasemight scalewith the probability of its gene to suffer
mutation with large ﬁtness effects [14]. Indeed, the frequencies of
disease genes were about 38% (728/1904) and 34% (583/1731) in P-L
and P-NL genes, respectively (p=3.86×10−14, odds ratio=3.02,
p=8.40×10−10, odds ratio=2.47, respectively, Figs. 1B, D), suggesting
that lethal genes, the genes related to more severe phenotypes in
mouse, are more likely to be human disease genes.
The most essential genes, embryonic lethal genes, are less likely to be
disease genes than postnatal lethal genes
Although lethal, so-called essential, genes contained more disease
genes than P-NL genes, the difference between these groups was
minute. To investigate this further, we compared two subgroups of P-L
genes; P-L-Em and P-L-Po genes. Surprisingly, P-L-Po geneswere found
to have the highest frequency of disease genes (47%, 255/541), whereas
P-L-Em genes contained only about 35% (473/1363) (Fig. 1C). The
frequency of disease genes in P-L-Em genes was similar to that of P-NL
genes (Fig.1C), which explains theminute difference in the frequencies
of disease genes between P-L and P-NL genes. These ﬁndings indicateFig. 2. Ka/Ks ratios were compared between disease and non-disease genes. The X-axis
label indicates the mouse phenotype groups.that P-L-Em genes are less likely to be disease genes than P-L-Po genes.
This inverse correlation between phenotypic severity in mouse and
incidence of linkagewith human diseasemay be due to strong negative
selection (i.e., spontaneous abortions). Based on these observations,
disease genes are apparently essential genes, given that P-L-Po genes, a
part of lethal (i.e., essential) genes, showed the highest frequency of
disease genes. Disease genes are, however, less likely to be extremely
essential genes such as embryonic lethal genes.
Essential non-disease genes evolve more slowly than essential
disease genes
Given that disease genes apparently display some characteristics of
essential genes, we examined whether disease genes evolve more
slowly than non-disease genes, similar to the manners reported for
essential genes [3,10]. The evolutionary ratewas calculated byKa/Ks ratio
using Li's method [18] between mouse and human orthologs, where Ka
is the nonsynonymous substitution rate and Ks is the synonymous
substitution rate (see Materials and methods). First, we conﬁrmed that
the genes with large ﬁtness effect evolve more slowly, so that P-L-Em
genes evolve the slowest (Ka/Ks=0.12) with P-L-Po genes the next
slowest (Ka/Ks=0.14), and P-NL and NP genes having relatively high
evolutionary rates (Ka/Ks=0.20). As described previously [1,3,4], it was
found that relatively nonessential genes (P-NL and NP genes) evolve
rapidly compared to relatively essential genes (P-L-Em and P-L-Po
genes). To examinewhetherdisease genes evolvemore slowly thannon-
disease genes, we compared Ka/Ks ratios between them (Fig. 2). Then,
the comparison was repeated within each of phenotype subgroups.
Nonessential genes did not show any statistically signiﬁcant difference
of Ka/Ks ratio between disease and non-disease genes (two-tailed t test,
pN0.1). However, non-disease genes in the P-L group were found to
evolve more slowly than disease genes in the same group (Ka/Ks=0.106
for non-disease versus Ka/Ks=0.136 for disease, two-tailed t test,
p=1×10−9). Since non-disease genes evolve more slowly than disease
genes in the P-L group (i.e. the group of essential genes), these essential
non-disease genes seem to be under the inﬂuence of more stringent
purifying selection than essential disease genes.
Types of disease mutations found in phenotype genes are different from
those in no phenotype genes
To examine whether the types of disease mutations occurred in
nonessential genes are different from those found in essential genes
(i.e. genes with a ﬁtness effect), we compared disease genes in P and
NP groups. We calculated the frequency at which each type of disease
mutations was found in disease genes of each group. As shown in Fig.
3, multiple types of mutations including nonsense, small indels, and
Fig. 4. The ratios of radical to conservative amino acid substitutions of disease
mutations were obtained among different mouse phenotype groups. Phenotype genes
were divided into non-lethal, postnatal lethal and embryonic lethal genes.
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disease genes in the P group than those in the NP group. Interestingly,
a signiﬁcantly higher frequency of regulatory mutations was found on
the disease genes in the NP group (Chi-squared test, pb0.05). Repeat
mutations also showed higher frequency in NP genes, but signiﬁcant
conclusion could not be drawn largely due to the small sample size.
The disease genes in the no phenotype group have more radical amino
acid mutations compared to those in the phenotype group
Fig. 3 indicates that the frequency of missense mutations on the
disease genes in the P group did not signiﬁcantly differ from those in
the NP group (Chi-squared test, p≫0.1). Considering that NP genes
encode relatively dispensable proteins and are subject to weaker
purifying selection, it is reasonable to expect that these proteins
require more radical amino acid changes to cause diseases. It is
generally assumed that radical amino acid changes are much more
likely to alter protein function than conservative substitutions [19–
21]. To test this hypothesis, a total 21,807 amino acid changes nested in
missense disease mutations were collected from HGMD, and were
assigned into phenotype groups accordingly. We then calculated the
ratio of radical amino acid substitutions to conservative amino acid
substitutions for each group. The severity (radical vs. conservative) of
amino acid changes was estimated based on Grantham's distance [20].
As hypothesized, missense disease mutations in NP genes were
signiﬁcantlymore likely to be derived from radical amino acid changes
(Fig. 4, Chi-squared test, p≪0.0001). There was no signiﬁcant
difference in the severity of amino acid changes among P-NL, P-L-
Po, and P-L-Em groups (Fig. 4).
Discussion
Our results showed that P genes aremore likely to be disease genes
than NP genes, supporting the idea that human disease genes have
properties of essential genes. Since P-L-Em genes were less likely to be
disease genes than P-L-Po genes, our data support previous ﬁndings
that disease genes are under an intermediate level of negative
selection pressure [17, 22]. This idea is also supported by the fact
that the difference of Ka/Ks ratios between disease and non-disease
genes was dramatically signiﬁcant in the P-L group, but not in both P-
NL and NP groups. These non-disease genes seemed to be under the
most stringent selection among all groups. Therefore, the lower Ka/Ks
ratio of non-disease genes could be explained by the effects of
extremely essential genes nested in non-disease genes outweighing
those of relatively nonessential and dispensable genes in human.
Taken together, all these ﬁndings consistently support the previous
notion that disease genes have ﬁtness effects, but may not be
extremely essential especially during early development [8,17].Genes contributing to organismic ﬁtness are considered to be
functionally important. A central tenet for the study of human gene
function is that the orthologs of ‘phenotype’ genes of a model
organism also perform an important analogous function [23]. As an
estimation of the essentiality of a human gene, we used phenotypic
consequences of mutations on mouse orthologs. Although the
relatively short evolutionarily distance between human and mouse
is an obvious advantage, it is clear some technical limits are placed on
our analysis. First, the number of mouse genes with a knownmutation
phenotype, comprises less than 20% of the genome (4004 genes).
Although this is relatively extensive, it may still have some bias
towards obvious phenotype genes or human disease genes. Second,
our analysis ignores certain aspects of the evolutionary process such
as positive selections in human lineage. Third, our estimation on
essentiality is not quantitative. Despite these methodological limita-
tions, however, we believe this methodology represents a useful and
complementary approach to existing methods.
In addition to the characteristics of human disease genes described
above, the characteristics of mutations linked with human disease
were compared between two subgroups of disease genes based on
their essentiality; disease mutations in P and NP genes. The disease
mutations in NP genes displayed signiﬁcantly frequent regulatory
mutations while those in P genes had a higher frequency of coding
mutations in human disease genes. Since disease genes in the NP
group are dispensable genes in mouse but may not be in human, this
raises the possibility that such genes become important in human
lineage by acquiring new, more important function(s) through
positive selection. We hypothesize that these newly acquired func-
tional changes may occur in regulatory regions. Indeed, it would be
interesting to see what phenotypes would be revealed if regulatory
regions in those genes were deleted or mutated in mice. Interestingly,
missense mutations found in nonessential disease genes are more
likely to be radical amino acid substitutions than those occurring in
essential disease genes. This is consistent with the idea that the
phenotypic severity of a genetic disease is determined by both the
essentiality of the gene and the degree of deleterious effect of the
mutation on the encoded protein. As previously noted [17], essenti-
ality of disease genes might be better described on a continuous
spectrum, although on average these genes remain intermediate to
extremely essential and completely dispensable genes. Different
mutations, as we describe here, may be one of the factors that
broaden the spectrum of essentiality of disease genes.
Features of human disease genes have drawnmuch attention, since
the signature found in known human disease genes can be used to
identify novel genes associated with human disease. However, simple
analysis of disease genes as a group lacks the power to accurately
illustrate the complex scenarios associated with human disease genes.
Along with previous studies using various classiﬁcations of human
disease genes, we suggest classiﬁcation of human disease genes based
on its essentiality as a useful option for further studies. We believe the
update of human disease genes combining with the development of
the analysis tools will expand the understanding of evolutionary
features in human disease genes in the future.
Materials and methods
Compiling lists of disease genes and mouse mutant phenotype genes
Lists of disease genes were obtained from HGMD (http://www.
hgmd.cf.ac.uk/ac/index.php). A license for downloading the profes-
sional version of the database was obtained from the Biobase Co. and
the databases were installed on a local sever computer. A total of 2789
genes were ﬁnally collected as human disease genes after removing
genes with no sequence information. We also obtained various
disease-associative information from the database such as types and
their number of mutation found in each disease gene, gene symbol,
418 D. Park et al. / Genomics 92 (2008) 414–418and gene length, etc. A total of 4004 ofmouse phenotype related genes
were obtained from MGI (http://www.informatics.jax. org/). We
collected only genes with mutations derived from knock-out, gene-
trap, and transgenic (gene-disruption) approaches, and classiﬁed
them into different groups as described in the Results section. The
mouse phenotype genes were linked to the human disease genes by
gene symbols using a home-built perl script. Among all the studied
genes, the human disease genes were listed in Supplementary Table 1
while the non-human disease genes were in Supplementary Table 2.
Both Table 1A and 1B classify genes based on the severity of mouse
phenotypes as described in the main text. Both tables contain gene
name (HUGO gene symbol), RefSeq gene identiﬁers of mouse and
human genes, mutation types and their frequencies found in human
disease, and evolutionary rate values including Ka, Ks, Ka/Ks ratio. In
addition, MGI and OMIM identiﬁers as well as gene descriptions were
summarized in Supplementary Table 2A and 2B, for the human
disease genes and the non-human disease genes, respectively.
Sequence collection and calculation of Ka/Ks ratio
To calculate Ka (nonsynonymous substitution rate) and Ks (synon-
ymous substitution rate), we ﬁrst obtained the coding sequences of
orthologs between human and mouse. We only retrieved Refseq
entries (ftp://ftp.ncbi.nih.gov) containing NM_ in the accession
numbers. We referred ‘gene_info’ and ‘gene2refseq’ ﬁles downloaded
from the NCBI ftp site (ftp://ftp.ncbi.nih.gov) to assign the gene
symbols to the corresponding Refseq sequences. Then, the coding
sequences were translated into amino acid sequences. Orthologs were
identiﬁed based on reciprocal best hits by BLASTP search with a cutoff
score of E=10−20. The 4004 mouse sequences and their human
orthologs were subtracted from the determined orthologs via perl
script. Sequences were aligned through ClustalW, and the Ka/Ks ratio
was calculated by the Li method [18].
Classiﬁcation of amino acid replacement by Grantham's distance
A total of 21,807missensemutations related to the human diseases
were downloaded from the HGMD and classiﬁed according to
Grantham's amino acid replacement distance matrix [19]. Following
previous convention [20,21], a Grantham's distance of 100 or less was
considered conservative and otherwise radical.
Statistical test
The logistic regressionmodelwas used to determinewhether or not
the phenotype genes in mouse are more likely to be disease genes in
human. Let Y be a binary response variable representing whether a
gene is linked to human disease or not. Explanatory variables represent
four groups of essentiality of the genes in mouse: NP, P-NL, P-L-Po, and
P-L-Em. Then, two types of logistic regression models were deﬁned as
follow:
log
π xð Þ
1−π xð Þ = β0 + β1x; ð1Þ
log
π xð Þ
1−π xð Þ = β0 + β1x1 + β2x2 + β3x3 ð2Þ
where π xð Þ = P Y = 1jX = xð Þ = 1−P Y = 0jX = xð Þ. In Model (1), one expla-
natory variable x, coded as 0 for NP, 1 for P-NL, 2 for P-L-Po, and 3 for
P-L-Em, was used. Note that this model uses ordinal information in
groups. On the other hand, Model (2) uses three indicator variables
treatingNP as a baseline group. That is, x1 is 1 for P-NL and 0 otherwise;
x2 and x3 are deﬁned similarly for P-L-Po and P-L-Em, respectively.
From the estimators of βs, the estimators of the odds ratio (eβ) can
be derived. When disease genes are more likely to be essential inmouse, the odds ratio would be larger than 1. The hypotheses for
comparing groups are H0: β1=0 for Model (1) and H0: β1=β2=β3=0
for Model (2). We used statistical package R for the analysis (http://
www.r-project.org/index.html).
Acknowledgments
This work was supported by the program of Nuclear R and D
program (M2070600005-08B0600-00510) of the Korea Science and
Engineering Foundation (KOSEF) and by the program of 2007
Research Grant from Kangwon National University. The work of
Jungsun Park and Taesung Park was supported by the National
Research Laboratory Program of Korea Science and Engineering
Foundation (M10500000126). We thank Noah M Walton and Tiffany
M Carr for critically reading this manuscript.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ygeno.2008.08.001.
References
[1] I.K. Jordan, I.B. Rogozin, Y.I. Wolf, E.V. Koonin, Essential genes are more
evolutionarily conserved than are nonessential genes in bacteria, Genome Res.
12 (2002) 962–968.
[2] S. Gerdes, R. Edwards, M. Kubal, M. Fonstein, R. Stevens, A. Osterman, Essential
genes on metabolic maps, Curr. Opin. Biotechnol. 17 (2006) 448–456.
[3] A.E. Hirsh, H.B. Fraser, Protein dispensability and rate of evolution, Nature 411
(2001) 1046–1049.
[4] J. Yang, Z. Gu, W.H. Li, Rate of protein evolution versus ﬁtness effect of gene
deletion, Mol. Biol. Evol. 20 (2003) 772–774.
[5] C. Pal, B. Papp, L.D. Hurst, Genomic function: rate of evolution and gene
dispensability, Nature 421 (2003) 496–497 discussion 497–498.
[6] E.P. Rocha, A. Danchin, An analysis of determinants of amino acids substitution
rates in bacterial proteins, Mol. Biol. Evol. 21 (2004) 108–116.
[7] H.B. Fraser, D.P. Wall, A.E. Hirsh, A simple dependence between protein evolution
rate and the number of protein–protein interactions, BMC Evol. Biol. 3 (2003) 11.
[8] K.I. Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal, A.L. Barabasi, The human disease
network, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8685–8690.
[9] H. Jeong, S.P. Mason, A.L. Barabasi, Z.N. Oltvai, Lethality and centrality in protein
networks, Nature 411 (2001) 41–42.
[10] D.P. Wall, A.E. Hirsh, H.B. Fraser, J. Kumm, G. Giaever, M.B. Eisen, M.W. Feldman,
Functional genomic analysis of the rates of protein evolution, Proc. Natl. Acad. Sci.
U. S. A. 102 (2005) 5483–5488.
[11] A.J. Butte, V.J. Dzau, S.B. Glueck, Further deﬁning housekeeping, or “maintenance,”
genes Focus on “A compendium of gene expression in normal human tissues”,
Physiol. Genomics 7 (2001) 95–96.
[12] J.A. Warrington, A. Nair, M. Mahadevappa, M. Tsyganskaya, Comparison of human
adult and fetal expression and identiﬁcation of 535 housekeeping/maintenance
genes, Physiol. Genomics 2 (2000) 143–147.
[13] S. Bortoluzzi, C. Romualdi, A. Bisognin, G.A. Danieli, Disease genes and intracellular
protein networks, Physiol. Genomics 15 (2003) 223–227.
[14] N. Lopez-Bigas, C.A. Ouzounis, Genome-wide identiﬁcation of genes likely to be
involved in human genetic disease, Nucleic Acids Res. 32 (2004) 3108–3114.
[15] E.P. Rocha, The quest for the universals of protein evolution, Trends Genet. 22
(2006) 412–416.
[16] H. Huang, E.E.Winter, H.Wang, K.G.Weinstock, H. Xing, L. Goodstadt, P.D. Stenson,
D.N. Cooper, D. Smith, M.M. Alba, C.P. Ponting, K. Fechtel, Evolutionary
conservation and selection of human disease gene orthologs in the rat and
mouse genomes, Genome Biol. 5 (2004) R47.
[17] Z. Tu, L. Wang, M. Xu, X. Zhou, T. Chen, F. Sun, Further understanding human
disease genes by comparing with housekeeping genes and other genes, BMC
Genomics 7 (2006) 31.
[18] W.H. Li, Unbiased estimation of the rates of synonymous and nonsynonymous
substitution, J. Mol. Evol. 36 (1993) 96–99.
[19] T. Dagan, Y. Talmor, D. Graur, Ratios of radical to conservative amino acid
replacement are affected by mutational and compositional factors and may not be
indicative of positive Darwinian selection, Mol. Biol. Evol. 19 (2002) 1022–1025.
[20] R. Grantham, Amino acid difference formula to help explain protein evolution,
Science 185 (1974) 862–864.
[21] A.L. Hughes, J.A. Green, J.M. Garbayo, R.M. Roberts, Adaptive diversiﬁcationwithin
a large family of recently duplicated, placentally expressed genes, Proc. Natl. Acad.
Sci. U. S. A. 97 (2000) 3319–3323.
[22] N.G. Smith, A. Eyre-Walker, Human disease genes: patterns and predictions, Gene
318 (2003) 169–175.
[23] A.E. Lathrop, L. Loeb, Further investigations on the origin of tumors in mice. III. On
the part played by internal secretion in the spontaneous development of tumors,
J. Cancer Res. 1 (1916) 1–19.
